Weight loss and leptin changes in individuals with type 2 diabetes

Area of Science:

• Metabolism and Endocrinology
• Diabetes Research
• Obesity and Weight Management

Background:

• Leptin, a key hormone in appetite regulation and energy balance, plays a role in metabolic disorders.
• Understanding leptin dynamics during weight loss is crucial for managing type 2 diabetes.
• Previous research has explored factors influencing leptin, but its specific changes during structured weight loss interventions in type 2 diabetes require further elucidation.

Purpose of the Study:

• To identify variables associated with changes in leptin levels in individuals with type 2 diabetes undergoing a 20-week weight loss program.
• To examine the relationship between weight loss, insulin levels, and leptin concentration over short-term (3 weeks) and long-term (20 weeks) periods.
• To investigate the impact of sulfonylurea medication on leptin and insulin levels during weight loss.

Main Methods:

• A 20-week behavioral weight control program was implemented for 54 subjects with type 2 diabetes.
• Leptin, fasting plasma glucose, and insulin levels were measured at baseline and at 3, 10, and 20 weeks.
• Data from seven subjects who restarted sulfonylureas after week 3 were analyzed separately.

Main Results:

• Significant weight loss (2.7 kg) at 3 weeks led to decreased leptin, glucose, and insulin levels (p<0.001).
• Further weight loss between weeks 3 and 20 did not alter leptin levels, with weight loss and initial leptin levels being primary determinants.
• Restarting sulfonylureas was associated with increased leptin and insulin levels despite continued weight loss.

Conclusions:

• Both short-term and long-term weight loss influence leptin changes in type 2 diabetes.
• Physiological insulin changes did not independently affect leptin concentration during weight loss.
• Sulfonylurea therapy can lead to increased leptin levels, independent of weight loss effects.